MPO and Stroke: Moreover, the manuscript examines the potential of NET components—such as double-stranded DNA, myeloperoxidase–DNA complexes, and citrullinated histone H3—as biomarkers for assessing disease severity and predicting adverse cardiovascular events, including ST-elevation myocardial infarction (STEMI) and stroke.